文献速递甲状腺疾病

甲状腺激素过度或替代不足与新发心力衰竭的关联

Association between over- and under-replacement with thyroid hormone and incident heart failure.
PubMed 文献 · J Clin Endocrinol Metab · 2026-01-01

结果显示,无论是替代不足还是过度替代,均与心力衰竭发生风险升高相关,且替代不足的关联更强、风险随时间累积。提示甲状腺激素治疗强度可能是可干预的心力衰竭危险因素。

要点

  • 替代不足与过度替代均与新发心力衰竭风险升高相关。
  • 替代不足的关联强于过度替代,且风险随时间累积。
  • 甲状腺激素治疗强度可能是可干预的心力衰竭危险因素。

核心结论

  • 甲状腺激素替代不足与过度替代均与新发心力衰竭风险升高相关,替代不足的关联更强。
  • 甲状腺激素治疗强度可能是心力衰竭的可干预危险因素。

研究设计与样本

  • 分析随时间变化的TSH与FT4暴露与新发心力衰竭的关系。

主要发现

  • 校正年龄、性别及心血管危险因素后,TSH>20 mIU/L的AOR为1.93(95%CI 1.84-2.02),FT4<0.7 ng/dL的AOR为1.08(95%CI 1.04-1.12)。
  • TSH<0.1 mIU/L的AOR为1.06(95%CI 1.01-1.12),FT4>1.9 ng/dL的AOR为1.23(95%CI 1.14-1.32)。
  • TSH>5.5 mIU/L与5年内新发心力衰竭增加5.8倍相关。

临床怎么用

  • 在甲状腺激素替代治疗中,应监测TSH与FT4,避免替代不足与过度替代。
  • 对接受甲状腺激素治疗者,可将心力衰竭风险纳入随访评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Whether over- or under-replacement with thyroid hormone is associated with incident heart failure remains unclear. OBJECTIVE: Elucidate the relationship between thyroid hormone over- and under-replacement and incident heart failure. DESIGN: Retrospective cohort study of 641 504 adults who initiated thyroid hormone treatment between 2004 and 2017 at the Veterans Health Administration. Two cohorts of adults aged ≥18 years treated with thyroid hormone were separately studied: 638 323 adults with at least 2 outpatient thyroid stimulating hormone (TSH) measurements, and 338 249 adults with at least 2 outpatient free thyroxine (FT4) measurements, between thyroid hormone initiation and incident heart failure or study conclusion. Associations between time-varying TSH and FT4 exposure and incident heart failure as the outcome were analyzed. RESULTS: Overall, 564 152/641 504 (87.9%) patients were men. Median age was 66 years. Incident heart failure occurred in 81 286/641 504 (12.7%) patients. Following adjustment for age, sex, and cardiovascular risk factors (eg, smoking, hypertension), under-replacement (eg, TSH > 20 mIU/L, adjusted odds ratio [AOR], 1.93, 95% CI, 1.84-2.02; FT4 < 0.7 ng/dL, AOR 1.08; 95% CI, 1.04-1.12) and over-replacement (eg, TSH < 0.1 mIU/L, AOR, 1.06; 95% CI, 1.01-1.12; FT4 > 1.9 ng/dL, AOR, 1.23; 95% CI, 1.14-1.32) were associated with increased incident heart failure compared to euthyroidism. Incident heart failure risk was cumulative over time with both thyroid hormone over- and under-replacement, but association was strongest with under-replacement (eg, TSH > 5.5 mIU/L associated with a 5.8-fold increase in incident heart failure over 5 years). CONCLUSION: Our findings suggest that thyroid hormone treatment intensity may be a modifiable risk factor for heart failure.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Evron J, Moretti B, Evans R, et al. Association between over- and under-replacement with thyroid hormone and incident heart failure. J Clin Endocrinol Metab. 2026. PMID: 41403272. doi:10.1210/clinem/dgaf677

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。